Search

everythinglearnresearchcommunity

for

Search:↓

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Biotin supplements significantly improve hair loss in people with telegon effluvium who lack biotin.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Doctors often miss Hair Tourniquet Syndrome, which can lead to serious damage if not treated quickly.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

ITK inhibitors may effectively treat alopecia areata.

TBX5 gene influences feathered feet in Guangxi chickens by affecting cell growth and movement.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Low zinc and copper levels may indicate Telogen Effluvium.

Adult skin cell-based early-stage skin substitutes improve wound healing and hair growth in mice.

Docetaxel is effective against various cancers but mainly causes neutropenia.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.

Hair loss from weight-loss treatments is usually temporary and reversible.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.